Home > PE Ratio > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
PE (Price/Earnings) Ratio

The Current P/E Ratio of KILITCH DRUGS (INDIA) is 30.83.

Share Price ₹345.0Apr 09,2025
Market Cap ₹555.5 Cr
Earnings-TTM₹18.0 CrTTM-Consolidated Results
Price/Earnings30.83xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of KILITCH DRUGS (INDIA)

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of KILITCH DRUGS (INDIA) is calculated as :

Current Market Cap [ ₹555.5 Cr] as on Apr 09,2025

(/) Earnings [ ₹18.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 30.83x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for KILITCH DRUGS (INDIA) , the investors are currently willing to pay 30.83 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KILITCH DRUGS (INDIA) !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of KILITCH DRUGS (INDIA) over the last five years.

Historical PE (Price/Earnings) ratio chart of KILITCH DRUGS (INDIA)


PE Ratio Performance Analysis for KILITCH DRUGS (INDIA)

- KILITCH DRUGS (INDIA) 's latest p/e ratio is 30.83x.

- KILITCH DRUGS (INDIA) 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 56.48x.

- KILITCH DRUGS (INDIA) 's operated at median p/e ratio of 35.47x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, KILITCH DRUGS (INDIA) 's p/e ratio peaked in Mar2020 at 148.95x.

- KILITCH DRUGS (INDIA) 's p/e ratio hit its five-year low in Mar2023 of 20.81x.


How does KILITCH DRUGS (INDIA) 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
KILITCH DRUGS (INDIA) 18.0230.83555.5
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0034.51396,394.0
DIVIS LABORATORIES LTD2,067.0069.14142,920.0
CIPLA LTD5,000.4322.87114,383.0
TORRENT PHARMACEUTICALS LTD1,862.0056.83105,817.0
DR REDDYS LABORATORIES LTD5,428.6016.8391,385.4
MANKIND PHARMA LTD2,050.7346.5695,481.0
ZYDUS LIFESCIENCES LTD4,591.8018.5184,986.5
LUPIN LTD2,892.1030.3387,719.8
AUROBINDO PHARMA LTD3,500.2517.5361,361.7
ABBOTT INDIA LTD1,334.4646.3961,912.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KILITCH DRUGS (INDIA) 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 16.83x
Max industry PE 69.14x
Median industry PE 30.83x
Average industry PE 35.49x



You may also like the below Video Courses